Asset Management One
AMAG

Asset Management One’s AMAG Pharmaceuticals AMAG Stock Holding History

Asset Management One’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-238,911
Closed -$5.75M – 1292
2016
Q3 		$5.75M Sell
238,911
-1,952
-0.8% -$48.8K 0.09% 265
2016
Q2 		$5.75M Buy
240,863
+24,207
+11% +$555K 0.09% 257
2016
Q1 		$4.79M Buy
216,656
+10,943
+5% +$260K 0.07% 325
2015
Q4 		$6.33M Buy
205,713
+62,084
+43% +$2.01M 0.09% 250
2015
Q3 		$5.52M Buy
143,629
+56,208
+64% +$3.49M 0.08% 294
2015
Q2 		$5.87M Sell
87,421
-5,652
-6% -$356K 0.08% 322
2015
Q1 		$5.23M Buy
+93,073
New +$4.44M 0.06% 378

Other funds holding AMAG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Asset Management One's AMAG Position: Q4 2016 in Review

Asset Management One sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 238,911 shares — an estimated $5.75M sold.

Asset Management One first reported a position in AMAG in Q1 2015 and held it in 7 quarters. The position peaked at $6.33M in Q4 2015. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • Asset Management One reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 238,911 AMAG Pharmaceuticals shares in Q4 2016, an estimated $5.75M.
  • Asset Management One first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Asset Management One's AMAG Pharmaceuticals position peaked at $6.33M in Q4 2015.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.